Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PRECIGEN, INC.XON · Entity 4356 | SVP, Finance | January 04, 2019 | January 08, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PRECIGEN, INC.
Report date January 04, 2019 · Filed January 08, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 99,315 |
Reported balance
After 2019-01-04 transaction · row 1
1 source rowRow 1 · 2019-01-04 · Grant · Acquired 13,774 · Balance 99,315 F1: These shares of common stock resulted from the grant and immediate vesting of restricted stock units that were issued as a portion of the reporting person's 2018 incentive compensation. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 75,758 |
Reported balance
After 2019-01-04 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-01-04 · Grant · Acquired 75,758 · Balance 75,758 F2: Each restricted stock unit represents a contingent right to receive one share of XON common stock. F3: The restricted stock units vest in four equal annual installments beginning January 4, 2020. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares of common stock resulted from the grant and immediate vesting of restricted stock units that were issued as a portion of the reporting person's 2018 incentive compensation.
F2: Each restricted stock unit represents a contingent right to receive one share of XON common stock.
F3: The restricted stock units vest in four equal annual installments beginning January 4, 2020.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 04, 2019 Filed Jan 4, 2019 18:46 UTC | PRECIGEN, INC. XON · Entity 4356 | SaleCommon Stock | 3,725 | $7.03 | $26,186.75 |
DisclosureSEC source: 0001123292-19-000081 · edgar.xml · nonDerivative · entry 2 LIFFMAN JOEL D · CIK 0001093734 · SVP, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,541 F2 · kind: This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of restricted stock units. Read SEC document |
| January 04, 2019 Filed Jan 8, 2019 20:08 UTC | PRECIGEN, INC. XON · Entity 4356 | GrantRestricted Stock Units · Derivative | 75,758 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-19-000132 · edgar.xml · derivative · entry 2 LIFFMAN JOEL D · CIK 0001093734 · SVP, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,758 Underlying: Common Stock · 75,758 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of XON common stock. F3 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning January 4, 2020. F3 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning January 4, 2020. Read SEC document |
| January 04, 2019 Filed Jan 8, 2019 20:08 UTC | PRECIGEN, INC. XON · Entity 4356 | GrantCommon Stock | 13,774 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001123292-19-000132 · edgar.xml · nonDerivative · entry 1 LIFFMAN JOEL D · CIK 0001093734 · SVP, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,315 F1 · price: These shares of common stock resulted from the grant and immediate vesting of restricted stock units that were issued as a portion of the reporting person's 2018 incentive compensation. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 18:46 UTC | PRECIGEN, INC. XON · Entity 4356 | Exercise / conversionRestricted Stock Units · Derivative | 9,766 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-19-000081 · edgar.xml · derivative · entry 3 LIFFMAN JOEL D · CIK 0001093734 · SVP, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,297 Underlying: Common Stock · 9,766 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of XON common stock. F3 · derivative.exercise_date: The restricted stock units were granted on January 2, 2018, and the remaining restricted stock units vest in three equal annual installments on each of January 2020, 2021 and 2022 F3 · derivative.expiration_date: The restricted stock units were granted on January 2, 2018, and the remaining restricted stock units vest in three equal annual installments on each of January 2020, 2021 and 2022 Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 18:46 UTC | PRECIGEN, INC. XON · Entity 4356 | Exercise / conversionCommon Stock | 9,766 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001123292-19-000081 · edgar.xml · nonDerivative · entry 1 LIFFMAN JOEL D · CIK 0001093734 · SVP, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,266 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of XON common stock. Read SEC document |
| October 15, 2018 Filed Oct 17, 2018 19:51 UTC | PRECIGEN, INC. XON · Entity 4356 | SaleCommon Stock | 79,000 | $14.59 | $1,152,807.50 |
DisclosureSEC source: 0001123292-18-001011 · edgar.xml · nonDerivative · entry 1 LIFFMAN JOEL D · CIK 0001093734 · SVP, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,500 F1 · kind: This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person. F2 · price: The price of $14.5925 per share represents a weighted average of sales prices ranging from $14.42 to $15.255 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| January 02, 2018 Filed Jan 8, 2018 20:19 UTC | PRECIGEN, INC. XON · Entity 4356 | GrantRestricted Stock Units · Derivative | 39,063 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-18-000101 · edgar.xml · derivative · entry 1 LIFFMAN JOEL D · CIK 0001093734 · SVP, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,063 Underlying: Common Stock · 39,063 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of XON common stock. F2 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning January 2, 2019. F2 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning January 2, 2019. Read SEC document |
| December 12, 2016 Filed Dec 13, 2016 07:09 UTC | PRECIGEN, INC. XON · Entity 4356 | PurchaseCommon Stock | 8,500 | $28.62 | $243,264.90 |
DisclosureSEC source: 0001225385-16-000086 · edgar.xml · nonDerivative · entry 1 LIFFMAN JOEL D · CIK 0001093734 · SVP, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,500 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $28.45 to $28.75, inclusive. The reporting person undertakes to provide to Intrexon Corporation ("Intrexon"), any security holder of Intrexon, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.